Markets

Market

News Details

(13/05/2026 14:20)

Suven Life Sciences posts Q4 net loss of Rs 11.17 cr

The company reported standalone net loss during the quarter stood at Rs 11.17 crore as compared to net loss of Rs 15.07 crore in the previous year quarter.

Net revenue of the company rose marginally by 3.40 per cent at Rs 1.52 crore in January-March quarter of this fiscal as against Rs 1.47 crore in the corresponding period last year.

During January-March quarter, operating expenses increased by 8.18 per cent to Rs 17.72 crore from Rs 16.38 crore in year ago period.

Other Income grew by 469.75 per cent at Rs 6.78 crore versus (Mar'25 Rs 1.19 crore).

Operating Profit surged by 8.65 per cent to Rs -16.20 crore as against Rs -14.91 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 4.86 per cent in March quarter.

Interest grew by 0.00 per cent y-o-y to Rs 0.16 crore

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.